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Abstract
Fluorophenylalanines bearing 2–5 fluorine atoms at the phenyl ring have been genetically encoded 
by amber codon. Replacement of F59, a phenylalanine residue that is directly involved in 
interactions with trimethylated K9 of histone H3, in the Mpp8 chromodomain recombinantly with 
fluorophenylalanines significantly impairs the binding to a K9-trimethylated H3 peptide.
Due to the size similarity between hydrogen and fluorine atoms, most fluorinated amino 
acids closely resemble their canonical counterparts. When provided in nutrients, they are 
usually mistaken as canonical amino acids by the cellular translation system and integrated 
into proteins at corresponding amino acid sites, therefore leading to mild to severe cellular 
toxicities.1 Biochemists have long been exploiting this promiscuity of the cellular translation 
system to generate fluorinated proteins.2 Owing to its high NMR signal that is sensitive 
toward surrounding environments, fluorine in proteins provides a unique probe to study 
protein structure and dynamics.3 Fluorine also has a more hydrophobic nature than 
hydrogen, which endows fluorinated proteins with unique features such as high resistance to 
denaturants.4 Although convenient in making fluorinated proteins, this residue-specific 
noncanonical amino acid (ncAA) mutagenesis approach typically leads to partial 
replacement of a native amino acid as a fluorinated amino acid at multiple sites in a protein 
and generates a highly heterogeneous final product that leads to complexity in subsequent 
studies. Consequently, methods for the synthesis of proteins bearing fluorinated amino acids 
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at user-defined sites are of high interest. A successful strategy at this front is the use of 
amber suppression that in the context of fluorinated amino acids was pioneered by Furter 
and later expanded by others.5
We previously reported two rationally designed, polyspecific mutants of Methanosarcina 
mazei pyrrolysyl-tRNA synthetase (PylRS) that enable the effective aminoacylation of 
tRNAPyl with a large variety of phenylalanine-derived ncAA for their incorporation into 
proteins by amber suppression. Of these, mutant N346A/C348A/Y306A/Y384F (PylRS-
AAAF) accepted phenylalanine derivatives with large substiutents at the para position as 
substrates,6 whereas N346A/C348A (PylRS-AA) accepted small phenylalanine derivatives,7 
including the NMR probe m-trifluoromethyl-phenylalanine.
To get insights into the origin of polyspecificity of PylRS-AA and into its lack of 
phenylalanine recognition, we determined the crystal structure of the C-terminal catalytic 
fragment (amino acids 188–454)8 in complex with the ATP analog adenosine-5′-(β,γ-
imido)triphosphate (AMPPNP) at a resolution of 1.5Å (the structure of PylRS-AAAF was 
also solved, for data collection and refinement statistics, see the SI).9 In wild type PylRS 
(PylRS_wt), N346 of the amino acid binding pocket serves as gate-keeper residue that is 
engaged in a variety of direct and water-mediated hydrogen bonds (Figure 1A). This 
includes donation of one bond to the Nε-carbonyl group of pyrrolysine adenylate, which is 
believed to be critical for pyrrolysine recognition.10 C348 forms part of the pocket bottom 
(Figure 1A). In the structure of PylRS-AA, the mutation of both residues to alanine results in 
an inability of hydrogen bonding, combined with an enlargement of the pocket, in particular 
at position 346 (Figure 1B). A related observation has been made in the context of a 
different mutant that accepts O-methyl-tyrosine as substrate.11
PylRS belongs to the aminoacyl-tRNA-synthetase subclass IIc that also includes PheRS 
from that PylRS has directly evolved, and both show similarity in their overall fold and in 
the organization of the core domain (Figure 1C).9 Our structure of PylRS-AA reveals 
similarities with PheRS in the front pocket dimension and polarity, despite marked 
differences in the type and orientation of the involved residues (Figure 1D, E). However, the 
overall pocket dimensions of PylRS-AA (in particular in the rear part) are larger, and in 
superimposed structures, both the Phe ligand and the pocket surface of PheRS can easily be 
accommodated in the pocket of PylRS-AA (Figure 1E). Specifically, in PheRS, residues 
including E210, F248, F250 and A294 form a very compact binding pocket for 
phenylalanine (Figure 1D). Consequently, though PheRS tolerates o, m, and p-
fluorophenylalanines as substrates, larger derivatives are usually expelled.12 Residues in 
PylRS-AA that correspond with E210 and A294 of PheRS are A346 and G41913 that bear 
no or shorter side chains. L305 in PylRS-AA is a homologous site of E174 in PheRS, but its 
side chain diverts from the pocket (not shown). Finally, F248 of PheRS has no homologous 
residue in PylRS-AA although Y384 of PylRS-AA partially occupies its space (Figure 1D, 
E). Taken together, the arrangement of active site residues of PylRS-AA leads to an enlarged 
amino acid binding pocket, and the differential availability of hydrophobic contacts for 
larger, substituted Phe-derivatives versus unsubstituted Phe may account for the observed 
selectivity of PylRS_AA (SI Figure 5).
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This structural comparison intrigued us to test the recognition of pentafluoro-phenylalanine 
(F5F, Figure 2A) by PylRS-AA. As expected, PylRS-AA does recognize F5F. E. coli BL21 
cells coding PylRS-AA, tRNAPyl, and sfGFP2TAG (superfolder green fluorescent protein 
(sfGFP) with an amber mutation at its S2 position) expressed full-length sfGFP when F5F 
was provided in the GMML medium, albeit with a low level (Supplementary Figure 1). In 
order to identify a PylRS mutant that in coordination with tRNAPyl shows an enhanced 
amber suppression rate in E. coli for more efficient incorporation of F5F into proteins, we 
constructed a small PylRS-AA-based mutant library by randomizing A348. A348 is spatially 
close to E174 in PheRS that locks phenylalanine restrictedly at the PheRS active site. By 
randomizing A348, we deemed that a better mutant with tighter binding of F5F could be 
identified. Screening all mutants led to the final identification of the mutant with S348 
(coined as PylRS-AS) that in coordination with tRNAPyl provided a higher efficiency of 
amber suppression in E. coli in the presence of F5F (Supplementary Figures 2 and 3).
To test the fidelity of PylRS-AS for the genetic incorporation of F5F in response to the 
amber codon, E. coli BL21 cells coding for PylRS-AS, tRNAPyl and sfGFP2TAG were 
grown in GMML medium with or without supplementing F5F. Cells grown in the presence 
of F5F produced full-length sfGFP (sfGFP-F5F) with an expression level of 10 mg/L, 
markedly contrasting to a negligible expression of full-length sfGFP in the absence of F5F 
(Figure 2B). This demonstrated that PylRS-AS accepts F5F as substrate but discriminates 
against canonical amino acids including Phe. Electrospray ionization mass spectrometry 
(ESI-MS) analysis of the purified sfGFP-F5F displayed a molecular weight of 27817 Da that 
agreed well with the theoretical mass at 27819 Da. The single dominant ESI-MS peak also 
indicated that F5F was not recognized by E. coli PheRS, which would lead to replacement of 
12 Phe residues in sfGFP during translation. Therefore the genetic encoding of F5F by 
amber codon is orthogonal to the endogenous translation system.
We next tested the ability of PylRS-AS for the acceptance of other fluorophenylalanines 
including 2,3,4,5-tetrafluorophenylalaine (F4F),14 3,4,5-trifluorophenylalanine (F3F), 3,5-
difluorophenylalanine (F2F), and 3,4-difluorophenylalanine (F2F’). When these 
fluorophenylalanines were present in the growth medium, E. coli BL21 cells coding for 
PylRS-AS, tRNAPyl and sfGFP2TAG expressed full-length sfGFP (Figure 2B). Expression 
levels under these conditions were similar to the condition with F5F. Molecular weights of 
purified full-length sfGFP proteins expressed in presence of F4F, F3F, and F2F (sfGFP-F4F, 
sfGFP-F3F, and sfGFP-F2F, respectively) determined by ESI-MS agreed well with 
theoretical molecular weights of these proteins (Figure 2C and Table 1). All three proteins 
exhibited a single dominant ESI-MS peak, establishing the orthogonality of genetic ncAA 
incorporation in respect to the endogenous translation system. However, the full-length 
sfGFP with F2F’ incorporated (sfGFP-F2F’) displayed multiple peaks in its ESI-MS 
spectrum. The smallest peak at 27765 Da matched the theoretic mass at 27763 Da. However, 
other peaks were all about multiples of 36 Da addition to the theoretical mass, clearly 
indicating that F2F’ displaced regular phenylalanine residues in sfGFP. This result 
demonstrated that the genetic encoding of F2F’ by amber codon is not orthogonal to the 
endogenous translation system, although PylRS-AS does recognize it as a substrate.
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In addition to being used as a NMR probe and to improve protein folding, genetically 
encoded fluorophenylalanines in proteins could potentially be for the investigation of cation-
pi interactions such as in the recognition of lysine methylation in histones by epigenetic 
readers. Being part of epigenetic regulation of chromatin function, histone lysine 
methylation induces interactions with effector proteins and subsequently regulates DNA 
replication, repair, and transcription.15 The recognition of methylated lysine typically 
involves an aromatic cage that has been found in the chromodomain (Figure 3A), the PHD 
finger, and the Tudor domain, and appears to be mediated by cation-pi interactions between 
the methylammonium moiety and aromatic residues in the cage.16 The cation-pi interaction 
is predominantly electrostatic, occuring between a cation and the quadruple moment of an 
aromatic π system (Figure 3B).17 As the quadruple moment places partial negative charge 
above each face of the aromatic ring, favorable interactions with a cation occur 
perpendicular to the aromatic plane within a typical van der Waals distance. Although a 
number of theoretical and experimental studies have been carried out to address the 
importance of the cation-pi interaction in the recognition of lysine methylation,18 it is not 
clear to what degree the cation-pi interaction contributes to the recognition specificity. A 
particularly interesting target protein to address this question is the Mpp8 chromodomain 
(Mpp8C). Mpp8 is a heterochromatin component that specifically recognizes and binds 
trimethylated K9 of histone H3 and promotes recruitment of proteins that mediate epigenetic 
repression.19 In Mpp8C, F59 is part of the aromatic cage that directly binds to trimethylated 
K9 of H3. Replacing this residue with fluorophenylalanines (in particular with F5F that has a 
strongly reduced partial negative charge above each face of the aromatic side chain) is 
expected to significantly reduce the binding of Mpp8C to trimethylated K9 of H3 in the case 
that the cation-pi interaction plays a dominant role. Otherwise, binding would not be 
strongly affected or might increase due to the more hydrophobic nature of 
fluorophenylalanines than phenylalanine.
Using our currently developed approach, Mpp8C with F59 replaced by the three derivatives 
F5F, F3F, and F2F were expressed. The incorporation of F5F in Mpp8C was independently 
confirmed with the detection of three19F NMR singals in the finally purified protein (SI 
Figure 6). Together with wild type Mpp8C, interactions of these proteins with a fluorescein-
conjugated N-terminal histone H3 peptide with trimethylation at the K9 position (FAM-
H3(1–15)K9me3) were studied using fluorescent polarization changes. As shown in Figure 
3C and Table 2, wild type Mpp8C interacts with FAM-H3(1–15)K9me3 strongly, with a 
determined Kd value around 0.8 µM that agrees with previously reported values.20 This 
binding was decreased 15-fold when F59 was replaced with F2F and continued to drop when 
F59 was replaced with F3F and F5F (Figures 3D–F and Table 2). Due to the low binding of 
FAM-H3(1–15)K9me3 to both F59F3F and F59F5F mutants of Mpp8C, no sufficient data 
could be collected to determine accurate Kd values between these two proteins and FAM-
H3(1–15)K9me3. This continuous decrease of binding of Mpp8C to FAM-H3(1–15)K9me3 
when a growing number of fluorine substituents are added to F59 strongly suggests that the 
cation-pi interaction plays a dominant role in the binding of trimethylated K9 of H3 to 
Mpp8C. Though hydrophobic interactions may contribute to the binding, they appear to be 
not significant, since adding hydrophobicity to F59 does not improve binding.
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In summary, a method for the genetic incorporation of fluorophenylalanines with fluorine 
substituents at the side chain phenyl ring ranging from 2 to 5 has been developed. This was 
based on a polyspecific PylRS mutant, its crystal structural analysis, and its further 
reengineering. The engineered PylRS mutants display recognition of fluorophenylalanines 
and discriminate against canonical amino acids including phenylalanine, assuring their 
specific incorporation in response to the amber codon. Using this method, we synthesized 
Mpp8C, a chromodomain with fluorophenylalanines replacing the critical active site residue 
F59 that directly interacts with trimethylated K9 of H3 for its binding to Mpp8C. We 
showed that replacing F59 with fluorophenylalanines significantly weakens the binding of 
Mpp8C to trimethylated K9 of H3. This result strongly supports a critical involvement of the 
cation-pi interaction in the recognition of lysine trimethylation by a chromodomain.
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Figure 1. Crystallographic analysis of PylRS-AA
(A) Amino acid binding pocket of PylRS-wt in complex with a pyrrolysyl-adenylate in a 
previously reported crystal structure (PDB entry: 2Q7H). Hydrogen bonds are shown as 
dotted yellow lines, water molecule as red sphere. Pocket surface is drawn transparent and 
colored according to atoms that form the surface. (B) Amino acid binding pocket of PylRS-
AA in complex with AMPPNP (PDB entry: 5KIP). Surface color code as in Fig. 1A. (C) 
Overview of superimposed crystal structures of E. coli PheRS (light blue) in complex with 
phenylalanine (Phe) and AMP (pdb entry 3PCO) and PylRS_AA (grey) in complex with 
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AMPPNP. The Phe ligand of PheRS is shown as sticks. (D) Amino acid binding pocket of 
PheRS with pocket-forming residues and Phe ligand shown as sticks. (E) Amino acid 
binding pocket of PylRS-AA with pocket-forming residues shown as sticks. PheRS structure 
was superimposed and Phe ligand (white sticks) and PheRS pocket surface (transparent light 
blue) are shown.
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Figure 2. The genetic incorporation of fluorophenylalanines
(A) Structures of five fluorophenylalanines. (B) The expression of sfGFP with 
fluorophenylalanines incorporated at its S2 position. To express full-length sfGFP, E. coli 
BL21 cells were transformed with two plasmids coding PylRS-AS, tRNAPyl, and 
sfGFP2TAG and the transformed cells were grown in the GMML medium supplemented 
with or without a fluorophenylalanine at 3 mM. (C) Deconvulated ESI-MS spectra of 
purified full-length sfGFP proteins. Theoretical molecular weights are 27819, 27801, 27783, 
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27765, and 27765 Da for sfGFP-F5F, sfGFP-F4F, sfGFP-F3F, sfGFP-F2F, and sfGFP-F2F’, 
respectively.
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Figure 3. 
(A) The structure of the MPP8 chromodomain (MPP8C) complexed with the H3(1–
15)K9me3 peptide (PDB: 3R93). (B) The cataion-quadrupole interaction. (C)–(F) 
Fluorescent polarization based binding assays of FAM-H3(1–15)K9me3 interactions with 
wild type MPP8C, MPP8C-F59F2F, MPP8C-F59F3F, and MPP8C-F5F. Data were fit to the 
equation: P=Pf+(Pb-Pf)*[protein]/(Kd+[protein]) where Pf and Pb are anisotropies of free 
and bond ligands.
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Table 1
Theoretical and detected molecular weights of different full-length sfGFP proteins.
Theoretical mass (Da) Detected mass (Da)
sfGFP-F5F 27819 27817
sfGFP-F4F 27801 27799
sfGFP-F3F 27783 27783
sfGFP-F2F 27765 27763
sfGFP-F2F’ 27765 27763, 27800, 27835, 27871,
27907
Chem Commun (Camb). Author manuscript; available in PMC 2017 October 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Lee et al. Page 13
Table 2
Determined dissociation constants between MPP8C proteins and FAM-H3(1–15)K9me3.
Kd (µM)
Wild type MPP8C 0.8 ± 0.1
MPP8C-F59F2F 12 ± 5
MPP8C-F59F3F > 100
MPP8C-F59F5F > 200
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